Almoosa board OKs 2.5% cash dividend for Q2 2026

06/08/2026 Argaam Exclusive

Almoosa Health Co. said its board of directors decided to distribute a 2.5% cash dividend, or SAR 0.25 a share, for the second quarter of 2026, according to a statement to Tadawul

 

Cash Dividends (Q2 2026)

Current Capital

SAR 443.04 mln

Number of Shares

44.30 mln

Total Dividends

SAR 11.08 mln

Percentage of Capital

2.5% (SAR 0.25 a share)

Record Date

Aug. 13, 2026

Payment Date

Aug. 27, 2026

 

Cash Dividends (H1 2026)

Total Dividends

SAR 22.16 mln

Percentage of Capital

5% (SAR 0.5/share)

Dividend History (SAR/share) Corporate Actions

Announcement Ex-Dividend Payment Dividends
(M Riyal)
Dividends * Notes
06/08/2026 13/08/2026 27/08/2026 11.08 0.25
12/05/2026 17/05/2026 07/06/2026 11.08 0.25
11/03/2026 29/03/2026 13/04/2026 15.51 0.35
02/11/2025 06/11/2025 20/11/2025 15.51 0.35
03/08/2025 07/08/2025 20/08/2025 15.51 0.35
22/05/2025 25/05/2025 03/06/2025 11.08 0.25
26/02/2025 20/05/2025 29/05/2025 44.30 1.00
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any

Dividend History

Consolidated cash dividend Cash dividend per share (SAR) * The stock price at the beginning of the period (SAR) Return on the base price
Last 3 Financial years N/A N/A N/A
Last 5 Financial years N/A N/A N/A
Last 10 Financial years N/A N/A N/A
Based on the beginning of the period (January 1 of the base year)

Historical Dividends

115.80
0.80 0.70 %

Valuation Data (Latest Share Price)

P/E (TTM) 30.92
Recurring P/E (TTM) 28.21
P/BV 2.61
Dividend Yield 0.74 %
Market Cap. (M) 5,129.95
Return on Average Assets 4.71 %
Return on Average Equity 8.71 %

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.